News
VANI
1.440
+2.13%
0.030
BRIEF-Vivani Medical Inc Says Estimate Cash Resources Are Sufficient To Fund Planned Operations Into Second Half Of 2024
Reuters · 11/14 22:52
Vivani Medical GAAP EPS of $0.04
Seekingalpha · 11/14 22:44
Vivani Medical Q3 EPS $0.04 Up From $(0.10) YoY
Benzinga · 11/14 22:33
BRIEF-Vivani Medical Reports Third Quarter 2022 Results, Provides Business Updates
Reuters · 11/14 22:25
-- Earnings Flash (VANI) VIVANI MEDICAL Reports Q3 EPS $0.04
-- Earnings Flash (VANI) VIVANI MEDICAL Reports Q3 EPS $0.04
MT Newswires · 11/14 16:57
Vivani Medical to Present at the ThinkEquity Investor Conference
EMERYVILLE, Calif., October 17, 2022--Vivani Medical, Inc. (NASDAQ: VANI) (the "Company" or "Vivani"), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced today that it will present at the ...
Business Wire · 10/17 10:00
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over the last 100 days. The company's market cap stands at $25.0 million.
Benzinga · 09/12 21:42
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Benzinga · 09/06 06:55
BRIEF-Vivani Announces Trading Under New Ticker Symbol (Nasdaq Vani)
BRIEF-Vivani Announces Trading Under New Ticker Symbol (Nasdaq Vani)
Reuters · 08/31 10:03
Second Sight, Nano Precision complete merger, renaming as Vivani Medical
Second Sight Medical Products (NASDAQ:EYES) <...
Seekingalpha · 08/30 10:21
BRIEF-Second Sight Medical Products Completes Merger With Nano Precision Medical
BRIEF-Second Sight Medical Products Completes Merger With Nano Precision Medical
Reuters · 08/30 10:06
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company&#39;s IPO on Thursday.
Benzinga · 08/22 06:33
ENDP, ANDX and PETZ among mid-day movers
Gainers: GigaCloud Technology Inc Class A Ordinary Shares (GCT) <font color="gre...
Seekingalpha · 08/19 17:04
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company&#39;s IPO on Thursday.
Benzinga · 08/19 16:23
Second Sight Medical sheds ~17% after reverse stock split
Second Sight Medical Products, Inc. (NASDAQ:EYES</sp...
Seekingalpha · 08/19 14:34
Axsome, Summit lead healthcare gainers; Accelerate Diagnostics, Bright Minds top losers
Gainers: Axsome Therapeutics (AXSM) +31%. Summit Therapeutics ...
Seekingalpha · 08/19 14:00
Coinbase Global, GameStop, MicroStrategy among premarket losers' pack
Bed Bath &amp; Beyond (BBBY) -43% after <a href="https://seekingalpha.c...
Seekingalpha · 08/19 12:28
BNGO, NTLA and OPTT are among pre market gainers
Applied DNA Sciences (APDN) +116%. Poseida Therapeutics (<a ...
Seekingalpha · 08/03 12:24
Second Sight stock rises as shareholders approve merger, name change, reverse stock split
Second Sight (NASDAQ:EYES) <a href="https://s...
Seekingalpha · 07/29 10:54
Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial
Second Sight Medical Products (NASDAQ:EYES) <...
Seekingalpha · 07/18 10:40
More
Webull provides a variety of real-time VANI stock news. You can receive the latest news about Vivani Medical through multiple platforms. This information may help you make smarter investment decisions.
About VANI
Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The Company is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The Company's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The Company's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.